Lupin, Ranbaxy Labs sue each other over patent disputes
LUPIN Limited and Ranbaxy Laboratories along with its parent company Daiichi Sankyo have slapped patent infringement charges against each other to stop one another from launching low-cost versions of their respective original drugs in the US.
Publication Date:
10/08/2010